Your browser doesn't support javascript.
loading
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): a topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration.
J Med Chem ; 51(6): 1546-59, 2008 Mar 27.
Article in En | MEDLINE | ID: mdl-18311895

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ophthalmic Solutions / Phenols / Triazines / Prodrugs / Macular Degeneration Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2008 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ophthalmic Solutions / Phenols / Triazines / Prodrugs / Macular Degeneration Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2008 Document type: Article Affiliation country: Country of publication: